Tissue and urokinase plasminogen activators in bone tissue and their regulation by parathyroid hormone
Open Access
- 1 October 1991
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 6 (10) , 1081-1090
- https://doi.org/10.1002/jbmr.5650061009
Abstract
The identification of the plasminogen activator (PA) types present in bone and the regulation of their activity by parathyroid hormone (PTH) were investigated in cultures of fetal mouse calvariae with the use of either a chromogenic substrate or a zymographic assay. PA was detected essentially in the tissue extracts of the explanted bones, with only 1–2% of the total activity released in the surrounding culture media. From their electrophoretic behavior compared to PAs of other mouse tissues and from their response to a specific antibody raised against the tissue type PA (tPA), two major molecular species, of 70 and 48 kD were identified as tPA and urokinase (uPA), respectively, a third minor species of 105 kD being likely to correspond to complexes between tPA and an inhibitor; the culture fluids, moreover, contained enzymatically active degradation products of uPA of 42 and 29 kD. The PA activity of the bone extracts was only minimally affected by the addition of fibrinogen fragments to the chromogenic assays. PTH induced bone resorption and stimulated in parallel the accumulation of PA in the tissue; other bone-resorbing agents, 1,25-dihydroxyvitamin D, and prostaglandin E2, had similar effects. Densitometric scanning of the zymograms of the bone extracts indicated that PTH stimulated only the production of tPA and had no effect on that of uPA. However, PTH also enhanced the release of uPA (both the 48 kD and the 29 kD forms) from the bones into the media. Although inhibiting bone resorption, calcitonin had no effect on the PTH-induced accumulation of PA in bone or on the release of tPA, but it prevented the PTH-induced accumulation of 29 kD uPA in the culture fluids. Thus these studies support the view that tPA and possibly also uPA may have a role in the physiology of bone; the nature of this role remains to be elucidated, however.Keywords
Funding Information
- Medical Scientific Research (88/93-122)
- National Fund for Scientific Research
This publication has 51 references indexed in Scilit:
- Regulation of plasminogen activation by components of the extracellular matrixBiochemistry, 1990
- The single-chain form of tissue-type plasminogen activator has catalytic activity: studies with a mutant enzyme that lacks the cleavage siteBiochemistry, 1989
- Heterogeneity of human tissue‐type plasminogen activatorFEBS Letters, 1988
- Epidermal Plasminogen Activator is Abnormal in Cutaneous LesionsJournal of Investigative Dermatology, 1988
- The effect of polymerised fibrin on the catalytic activities of one-chain tissue-type plasminogen activator as revealed by an analogue resistant to plasmin cleavageBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1988
- A new synthetic inhibitor of mammalian tissue collagenase inhibits bone resorption in cultureBiochemical and Biophysical Research Communications, 1985
- In vivo and in vitro evidence for the involvement of cysteine proteinases in bone resorptionBiochemical and Biophysical Research Communications, 1984
- Comparative electrophoretic analysis of human and porcine plasminogen activators in sds-polyacrylamide gels containing plasminogen and caseinBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1983
- A critical role of lysine residues in the stimulation of tissue plasminogen activator by denatured proteins and fibrin clotsBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1983
- Plasminogen Activator Released as Inactive Proenzyme from Murine Cells Transformed by Sarcoma VirusEuropean Journal of Biochemistry, 1982